The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).
Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.
The global Inhaled Nitric Oxide market was valued at US$ 1084 million in 2023 and is anticipated to reach US$ 1906.6 million by 2030, witnessing a CAGR of 8.3% during the forecast period 2024-2030.
Mallinckrodt monopolizes the global Inhaled Nitric Oxide market, holding a share about 65%.
North America is the largest market, with a share about 77%, followed by Asia-Pacific and Europe, have a share about 20 percent.
In terms of product, 800 ppm is the largest segment, with a share over 50%. And in terms of application, the largest application is Near-term and Pre-term Infants PPHN, followed by Children and Adult ARDS, etc.
This report aims to provide a comprehensive presentation of the global market for Inhaled Nitric Oxide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaled Nitric Oxide.
Report Scope
The Inhaled Nitric Oxide market size, estimations, and forecasts are provided in terms of sales volume (M L) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inhaled Nitric Oxide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhaled Nitric Oxide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Mallinckrodt
- Praxair (Linde plc)
- Air Liquide
- BOC Healthcare (Linde Group)
Segment by Type
- 800 ppm
- 100 ppm
- Others
Segment by Application
- Near-term and Pre-term Infants PPHN
- Children and Adult ARDS
- Other Diseases
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inhaled Nitric Oxide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inhaled Nitric Oxide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Inhaled Nitric Oxide Market Overview
1.1 Product Overview and Scope of Inhaled Nitric Oxide
1.2 Inhaled Nitric Oxide Segment by Type
1.2.1 Global Inhaled Nitric Oxide Market Value Comparison by Type (2024-2030)
1.2.2 800 ppm
1.2.3 100 ppm
1.2.4 Others
1.3 Inhaled Nitric Oxide Segment by Application
1.3.1 Global Inhaled Nitric Oxide Market Value by Application: (2024-2030)
1.3.2 Near-term and Pre-term Infants PPHN
1.3.3 Children and Adult ARDS
1.3.4 Other Diseases
1.4 Global Inhaled Nitric Oxide Market Size Estimates and Forecasts
1.4.1 Global Inhaled Nitric Oxide Revenue 2019-2030
1.4.2 Global Inhaled Nitric Oxide Sales 2019-2030
1.4.3 Global Inhaled Nitric Oxide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Inhaled Nitric Oxide Market Competition by Manufacturers
2.1 Global Inhaled Nitric Oxide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Inhaled Nitric Oxide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Inhaled Nitric Oxide Average Price by Manufacturers (2019-2024)
2.4 Global Inhaled Nitric Oxide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inhaled Nitric Oxide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inhaled Nitric Oxide, Product Type & Application
2.7 Inhaled Nitric Oxide Market Competitive Situation and Trends
2.7.1 Inhaled Nitric Oxide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Inhaled Nitric Oxide Players Market Share by Revenue
2.7.3 Global Inhaled Nitric Oxide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Inhaled Nitric Oxide Retrospective Market Scenario by Region
3.1 Global Inhaled Nitric Oxide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Inhaled Nitric Oxide Global Inhaled Nitric Oxide Sales by Region: 2019-2030
3.2.1 Global Inhaled Nitric Oxide Sales by Region: 2019-2024
3.2.2 Global Inhaled Nitric Oxide Sales by Region: 2025-2030
3.3 Global Inhaled Nitric Oxide Global Inhaled Nitric Oxide Revenue by Region: 2019-2030
3.3.1 Global Inhaled Nitric Oxide Revenue by Region: 2019-2024
3.3.2 Global Inhaled Nitric Oxide Revenue by Region: 2025-2030
3.4 North America Inhaled Nitric Oxide Market Facts & Figures by Country
3.4.1 North America Inhaled Nitric Oxide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Inhaled Nitric Oxide Sales by Country (2019-2030)
3.4.3 North America Inhaled Nitric Oxide Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Inhaled Nitric Oxide Market Facts & Figures by Country
3.5.1 Europe Inhaled Nitric Oxide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Inhaled Nitric Oxide Sales by Country (2019-2030)
3.5.3 Europe Inhaled Nitric Oxide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inhaled Nitric Oxide Market Facts & Figures by Country
3.6.1 Asia Pacific Inhaled Nitric Oxide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Inhaled Nitric Oxide Sales by Country (2019-2030)
3.6.3 Asia Pacific Inhaled Nitric Oxide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Inhaled Nitric Oxide Market Facts & Figures by Country
3.7.1 Latin America Inhaled Nitric Oxide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Inhaled Nitric Oxide Sales by Country (2019-2030)
3.7.3 Latin America Inhaled Nitric Oxide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inhaled Nitric Oxide Market Facts & Figures by Country
3.8.1 Middle East and Africa Inhaled Nitric Oxide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Inhaled Nitric Oxide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Inhaled Nitric Oxide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Inhaled Nitric Oxide Sales by Type (2019-2030)
4.1.1 Global Inhaled Nitric Oxide Sales by Type (2019-2024)
4.1.2 Global Inhaled Nitric Oxide Sales by Type (2025-2030)
4.1.3 Global Inhaled Nitric Oxide Sales Market Share by Type (2019-2030)
4.2 Global Inhaled Nitric Oxide Revenue by Type (2019-2030)
4.2.1 Global Inhaled Nitric Oxide Revenue by Type (2019-2024)
4.2.2 Global Inhaled Nitric Oxide Revenue by Type (2025-2030)
4.2.3 Global Inhaled Nitric Oxide Revenue Market Share by Type (2019-2030)
4.3 Global Inhaled Nitric Oxide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Inhaled Nitric Oxide Sales by Application (2019-2030)
5.1.1 Global Inhaled Nitric Oxide Sales by Application (2019-2024)
5.1.2 Global Inhaled Nitric Oxide Sales by Application (2025-2030)
5.1.3 Global Inhaled Nitric Oxide Sales Market Share by Application (2019-2030)
5.2 Global Inhaled Nitric Oxide Revenue by Application (2019-2030)
5.2.1 Global Inhaled Nitric Oxide Revenue by Application (2019-2024)
5.2.2 Global Inhaled Nitric Oxide Revenue by Application (2025-2030)
5.2.3 Global Inhaled Nitric Oxide Revenue Market Share by Application (2019-2030)
5.3 Global Inhaled Nitric Oxide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Mallinckrodt
6.1.1 Mallinckrodt Corporation Information
6.1.2 Mallinckrodt Description and Business Overview
6.1.3 Mallinckrodt Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Mallinckrodt Inhaled Nitric Oxide Product Portfolio
6.1.5 Mallinckrodt Recent Developments/Updates
6.2 Praxair (Linde plc)
6.2.1 Praxair (Linde plc) Corporation Information
6.2.2 Praxair (Linde plc) Description and Business Overview
6.2.3 Praxair (Linde plc) Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Praxair (Linde plc) Inhaled Nitric Oxide Product Portfolio
6.2.5 Praxair (Linde plc) Recent Developments/Updates
6.3 Air Liquide
6.3.1 Air Liquide Corporation Information
6.3.2 Air Liquide Description and Business Overview
6.3.3 Air Liquide Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Air Liquide Inhaled Nitric Oxide Product Portfolio
6.3.5 Air Liquide Recent Developments/Updates
6.4 BOC Healthcare (Linde Group)
6.4.1 BOC Healthcare (Linde Group) Corporation Information
6.4.2 BOC Healthcare (Linde Group) Description and Business Overview
6.4.3 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Product Portfolio
6.4.5 BOC Healthcare (Linde Group) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inhaled Nitric Oxide Industry Chain Analysis
7.2 Inhaled Nitric Oxide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inhaled Nitric Oxide Production Mode & Process
7.4 Inhaled Nitric Oxide Sales and Marketing
7.4.1 Inhaled Nitric Oxide Sales Channels
7.4.2 Inhaled Nitric Oxide Distributors
7.5 Inhaled Nitric Oxide Customers
8 Inhaled Nitric Oxide Market Dynamics
8.1 Inhaled Nitric Oxide Industry Trends
8.2 Inhaled Nitric Oxide Market Drivers
8.3 Inhaled Nitric Oxide Market Challenges
8.4 Inhaled Nitric Oxide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
